The U.S. Food and Drug Administration announced late Thursday it has approved expanding the use of Eli Lilly’s ( LLY ) blockbuster antidepressant Cymbalta to treat chronic musculoskeletal pain, such as osteoarthritis and lower back pain. “Up to three …
Continued here:
Eli Lilly Antidepressant Cymbalta Approved for Chronic Pain – Daily Finance
